AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Aug 29, 2012
30071_dirs_2012-08-29_43b02c6f-a1e8-46b4-947f-f05caf1695b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-27
Reporting Person: WAREHAM JOHN P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-27 | ResMed Common Stock | M | 18000 | $21.025 | Acquired | 31000 | Direct |
| 2012-08-27 | ResMed Common Stock | S | 18000 | $37.341 | Disposed | 13000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-27 | ResMed NQ Stock Options | $21.025 | M | 18000 | Disposed | 2014-11-07 | ResMed Common Stock (18000) | Direct |
Footnotes
F1: There is a holding period until the earlier of 3 years from the date of grant or 6 months from the termination of directorship.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29